Figure 4From: Circulating miR-200c and miR-141 and outcomes in patients with breast cancerPoor prognostic blood miRNA signature. Kaplan-Meier analysis and log-rank test showed that patients with higher levels of blood miR-200c and/or low levels of miR-141 had significantly poorer progression-free survival (A) and overall survival (B).Back to article page